The Anatomy of a World-Class Primary Research Provider
A buyer’s framework for investment teams evaluating primary research vendors. Criteria, red flags, and the questions that separate providers who deliver edge from those who sell access.
Read more
Lilly's CrossBridge Bet: Does a $300M Dual-Payload ADC Deal Signal Obsolescence Risk for Today's TROP2 Leaders?
Eli Lilly pays up to $300M for a pre-clinical startup with zero human data. We are launching primary research to determine what that price tag reveals about the competitive ceiling on single-payload TROP2 ADCs from AstraZeneca, Daiichi Sankyo, and Gilead.
Primary Research for Hedge Funds: How to Use Expert Networks, Surveys, and Channel Checks to Build and Challenge Investment Theses
A practical guide for hedge fund analysts on structuring primary research — expert calls, surveys, and channel checks — to build conviction, challenge theses, and generate alpha in an increasingly competitive market.
Commercial Due Diligence for Private Equity: The Definitive Guide for 2026
A practical guide to commercial due diligence in PE — covering the CDD process, the role of primary research, common pitfalls, and how deal teams can build real conviction before committing capital.
How Consultants Can Use Expert Networks to Win and Deliver Commercial Due Diligence Mandates
A practical guide for consulting teams competing for PE commercial due diligence work. Learn how to scope expert programmes, design discussion guides, and deliver PE-grade primary research — even with a lean team.